 |
Arsenal Medical
Last updated: October 12, 2024
Maria Palasis, President and CEO
USA | Funding: $71.4M (+)
Website: https://arsenalmedical.com/
Arsenal Medical uses conventional biomaterials in unconventional ways to develop novel products that improve local therapy for injury and disease. The company is advancing multiple preclinical programs based on both its two proprietary technology platforms: its therapeutic foam and AxioCore, a novel, high-throughput nanofiber technology.
Website: https://arsenalmedical.com/
Arsenal Medical uses conventional biomaterials in unconventional ways to develop novel products that improve local therapy for injury and disease. The company is advancing multiple preclinical programs based on both its two proprietary technology platforms: its therapeutic foam and AxioCore, a novel, high-throughput nanofiber technology.
